British pharmaceutical giant AstraZeneca announced on Friday that it will invest $2.5 billion in a research and development ...

AstraZeneca plans to build a $2.5 billion research and development center in Beijing, the Britain-based multinational ...

BEIJING] AstraZeneca will invest US$2.5 billion in a new research centre in Beijing, in a major show of commitment to China ...

AstraZeneca Plc will invest $2.5 billion in a new research center in Beijing, in a major show of commitment to China just ...

British-Swedish pharmaceutical titan AstraZeneca revealed a USD2.5 billion investment in Beijing, reinforcing its dedication to advancing ...

The pharmaceutical company said the investment in the research-and-development center in Beijing will bolster its footprint ...

Tallying up a wide range of investments, AstraZeneca said it is pumping $2.5 billion into Beijing. The figure includes ...

This $2.5 billion investment reflects AstraZeneca's belief in "the world-class life sciences ecosystem in Beijing" and its ...

AstraZeneca (AZN) announced an investment of $2.5B in Beijing to establish its sixth global strategic R&D center together with major ...

AstraZeneca AZN-0.91%decrease ... pharmaceutical giant said Friday that it will build a new research center in Beijing, its sixth globally, that will focus on early-stage research and clinical ...

AstraZeneca on Friday said that it will invest $2.5 billion in a research and development center in Chinese capital Beijing, months after the British pharmaceutical giant faced local regulators ...